Zdrowie i gospodarka · 09/10/2008
FDA Releases Draft Guidance on Potency Tests for Cellular and Gene Therapy Products
The FDA has made available a draft document outlining recommended potency tests for manufacturers of cellular and gene therapy products, aiming to support IND and BLA applications
Source: Federal Register — Food and Drug AdministrationOpen original release →